Unni Krishnan

Unni Krishnan

Auto-generated profile, based on publicly available information

Unni Krishnan

Cardiology Unit, Cambridge University Hospitals NHS Foundation Trust , Cambridge

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 November 2020 in European Heart Journal - Case Reports
Verified
Journal Article
Open access
PDF file
KVKamen Valchanov
Kamen Valchanov
UKUnni Krishnan
Unni Krishnan
SHStephen P Hoole
Stephen P Hoole
WDWill R Davies
Will R Davies
SPStephen Pettit
Stephen Pettit
MBMarius Berman
Marius Berman
Background: COVID-19 can present with cardiovascular complications. Case summary: We present a case report of a 43-year-old previously fit patient who suffered from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection with thrombosis of the coronary arteries causing acute myocardial infarction. These were treated with coronary stenting during which the patient suffered cardiac arrest. He was supported with automated chest compressions followed by peripheral veno-arterial extracorporeal membrane oxygenation (VA ECMO). No immediate recovery of the myocardial function was observed and, after insufficient venting of the left ventricle was diagnosed, an Impella 5 pump was implanted. The cardiovascular function recovered sufficiently and ECMO was explanted and inotropic infusions discontinued. Due to SARS-CoV-2 pulmonary infection, hypoxia became resistant to conventional mechanical ventilation and the patient was nursed prone overnight. After initial recovery of respiratory function, the patient received a tracheostomy and was allowed to wake up. Following a short period of agitation his neurological function recovered completely. During the third week of recovery, progressive multisystem dysfunction, possibly related to COVID-19, developed into multiorgan failure, and the patient died. Discussion: We believe that this is the first case report of coronary thrombosis related to COVID-19. Despite the negative outcome in this patient, we suggest that complex patients may in the future benefit from advanced cardiovascular support, and may even be nursed safely in the prone position with Impella devices.

23 September 2025 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Closed access
RDRudolf Duehmke
Rudolf Duehmke
MHMalek Hassan
Malek Hassan
APAravinda Page
Aravinda Page
UKUnni Krishnan
Unni Krishnan
PDPhilip Dong
Philip Dong
SPStephen James Pettit
Stephen James Pettit
Objectives: Donation after circulatory-determined death (DCD) heart transplantation has increased the number of hearts available for transplantation by 30%-40%. This may be associated with improved clinical outcomes for patients waiting for transplantation. We compare clinical outcomes from registration on the transplant waiting list before and after establishment of a DCD heart transplant programme. Methods: Observational cohort study of all patients listed for heart transplantation at a single centre for 3 years before (cohort 1) and 3 years after (cohort 2) the start of a DCD heart transplant programme. Outcome measures included heart transplantation, removal from waiting list due to death or deterioration, removal from waiting list due to improvement or patient choice, and need for mechanical circulatory support (MCS) after listing for heart transplantation. Results: One hundred twenty-nine patients were registered on the waiting list in cohort 1 and 146 patients in cohort 2. Patients in cohort 1 underwent 91 donation after brainstem-determined death (DBD) and 12 DCD heart transplants. Patients in cohort 2 underwent 102 DBD and 32 DBD heart transplants. Compared with cohort 1, patients in cohort 2 had a shorter waiting time for transplantation (45 vs 77 days, P = 0.001) and an increased cumulative incidence of transplantation (P < 0.001). When all patients had reached an end-point, patients in cohort 2 had a lower likelihood of death or removal from waiting list due to deterioration (6% vs 18%, P = 0.011) and fewer patients in cohort 2 required MCS after listing (4.1% vs 13.9%, P = 0.007). Conclusions: In a single centre, introduction of a DCD heart transplant programme was associated with shorter waiting times for heart transplantation and a lower likelihood of death/deterioration or requirement for MCS while waiting for heart transplantation.